BRAF+ melanoma: BRAF/MEK, PD-1 inhibition best for OS
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
Why this matters
- BRAF/MEK and PD-1 inhibition significantly improved OS in this population.
- The favorable safety profile of PD-1 inhibitors lends support to its use as a first-line option when rapid response is not a priority.
- Meta-analysis that included 16 articles reportin...